fda report title "voice of the patient" kidney transplant recipient

by Miss Fleta Grady I Published 3 years ago Updated 2 years ago 9 min read

The Voice of the Patient - fda.gov

35 hours ago · The Voice of the Patient . A series of reports from the U.S. Food and Drug Administration’s (FDA’s) ... have received an organ transplant, FDA believes that the input received reflects a range ... >> Go To The Portal

When was the FDA meeting on stimulant use disorder?

On October 6, 2020 , FDA hosted a public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting provided FDA the opportunity to obtain input from individuals with stimulant use disorder and other stakeholders on the impact of stimulant use disorder and views on treatment goals and approaches. FDA was interested in hearing perspectives from individuals with stimulant use disorder on the health effects and daily impacts of their stimulant use disorder, impact (if any) of opioid and polysubstance use on their stimulant use disorder, treatment goals, and decision factors considered when seeking out or selecting a treatment.

When was the FDA meeting on Chagas disease?

On April 28, 2015, FDA conducted a public meeting on Patient-Focused Drug Development for Chagas Disease. FDA was interested in obtaining patient perspectives on the impact of Chagas Disease on daily life and patient views on treatment approaches.

What happens when the kidneys are damaged?

Chronic kidney disease occurs when the kidneys are damaged and cannot filter blood normally. Due to this defective filtering, patients can have complications related to fluid, electrolytes (minerals required for many bodily processes), and waste build-up in the body. Chronic kidney disease sometimes can progress to kidney failure.

What is the FDA?

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

Does Farxiga help with kidney failure?

Chronic kidney disease sometimes can progress to kidney failure. Patients also are at high risk of cardiovascular disease, including heart disease and stroke. The efficacy of Farxiga to improve kidney outcomes and reduce cardiovascular death in patients with chronic kidney disease was evaluated in a multicenter, double-blind study.